UKPDS Risk Engine, decode and diabetes PHD models for the estimation of cardiovascular risk in patients with diabetes
- PMID: 20034373
- DOI: 10.2174/157339910790442646
UKPDS Risk Engine, decode and diabetes PHD models for the estimation of cardiovascular risk in patients with diabetes
Abstract
Individuals with type 2 diabetes have a two to four fold increased risk for developing cardiovascular disease than persons without diabetes. The presence of traditional and nontraditional risk factors that frequently coexist with type 2 diabetes are associated with this higher cardiovascular risk. Diabetes itself has been considered a cardiovascular disease equivalent. Nevertheless, the American Diabetes Association has recognized that absolute risk for cardiovascular disease varies among individuals with diabetes and has recommended the use of designed models and algorithms to estimate risk, especially in younger patients (<40 years). Cardiovascular risk is best evaluated with an estimation that takes into account the individual's characteristics and risk factors. The algorithms and models that have been designed specifically for the assessment of cardiovascular risk in individuals with diabetes will be the subject of this review. Specifically, the DECODE (Diabetes Epidemiology: Collaborative analysis of Diagnostic criteria in Europe) equation has been shown to have discriminative capacity of 0.67; the UKPDS Risk Engine model is reported to have a sensitivity of around 90% and specificity of 33%; and the Diabetes Personal Health Decisions (PHD) in our study had a sensitivity of 67% and specificity of 41%. In this review we will discuss the pros and cons of each model, their use in clinical practice and the application of the UKPDS risk engine and PHD model in a Mexican population.
Similar articles
-
Skin autofluorescence provides additional information to the UK Prospective Diabetes Study (UKPDS) risk score for the estimation of cardiovascular prognosis in type 2 diabetes mellitus.Diabetologia. 2009 May;52(5):789-97. doi: 10.1007/s00125-009-1308-9. Epub 2009 Mar 10. Diabetologia. 2009. PMID: 19274450
-
Cardiovascular risk assessment in type 2 diabetes mellitus: comparison of the World Health Organization/International Society of Hypertension risk prediction charts versus UK Prospective Diabetes Study risk engine.Vasc Health Risk Manag. 2015 Nov 13;11:583-9. doi: 10.2147/VHRM.S90126. eCollection 2015. Vasc Health Risk Manag. 2015. PMID: 26622181 Free PMC article.
-
Comparison of different vascular risk engines in the identification of type 2 diabetes patients with high cardiovascular risk.BMC Cardiovasc Disord. 2015 Oct 13;15:121. doi: 10.1186/s12872-015-0120-3. BMC Cardiovasc Disord. 2015. PMID: 26464076 Free PMC article.
-
Comparative performance of diabetes-specific and general population-based cardiovascular risk assessment models in people with diabetes mellitus.Diabetes Metab. 2013 Oct;39(5):389-96. doi: 10.1016/j.diabet.2013.07.002. Epub 2013 Sep 27. Diabetes Metab. 2013. PMID: 24080092 Review.
-
Dyslipidaemia and cardiovascular risk in diabetes.Diabetes Obes Metab. 1999 Jul;1(4):189-98. doi: 10.1046/j.1463-1326.1999.00030.x. Diabetes Obes Metab. 1999. PMID: 11228753 Review. No abstract available.
Cited by
-
Association of helicobacter pylori infection with lipid metabolism and 10-year cardiovascular risk in diabetes mellitus: A cross-sectional study.PLoS One. 2025 Apr 9;20(4):e0319688. doi: 10.1371/journal.pone.0319688. eCollection 2025. PLoS One. 2025. PMID: 40203057 Free PMC article.
-
Estimated incidence of cardiovascular complications related to type 2 diabetes in Mexico using the UKPDS outcome model and a population-based survey.Cardiovasc Diabetol. 2011 Jan 7;10:1. doi: 10.1186/1475-2840-10-1. Cardiovasc Diabetol. 2011. PMID: 21214916 Free PMC article.
-
The Lifestyle Intervention for the Treatment of Diabetes study (LIFT Diabetes): Design and baseline characteristics for a randomized translational trial to improve control of cardiovascular disease risk factors.Contemp Clin Trials. 2017 Feb;53:89-99. doi: 10.1016/j.cct.2016.12.005. Epub 2016 Dec 7. Contemp Clin Trials. 2017. PMID: 27940180 Free PMC article. Clinical Trial.
-
The Possible Effect of the Long-Term Use of Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) on Hba1c and Lipid Profile in Type 2 Diabetes Mellitus: A Retrospective Study in KAUH, Jeddah, Saudi Arabia.Diseases. 2023 Mar 14;11(1):50. doi: 10.3390/diseases11010050. Diseases. 2023. PMID: 36975599 Free PMC article.
-
Contemporary Cardiovascular Risk Assessment for Type 2 Diabetes Including Heart Failure as an Outcome: The Fremantle Diabetes Study Phase II.J Clin Med. 2020 May 11;9(5):1428. doi: 10.3390/jcm9051428. J Clin Med. 2020. PMID: 32403446 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous